Novocure (NVCR) 2025 Earnings Outlook and Analysis
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Looking for short term gigs? Discover where to find quick cash options that fit your schedule.
25,797 articlesNovocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Geopolitics can push oil to $100 a barrel, but certain pipeline stocks thrive on throughput rather than price. Learn ...
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
Long-term investing thrives on steady income and durable growth. This guide explains why a dividend that belongs almo...
January delivered a painful wake-up call for Duolingo investors as the stock dropped sharply. This guide unpacks the ...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Power Solutions International posted a softer-than-expected Q1 2026, with revenue miss and shrinking margins. Data-ce...
Zscaler's Q2 2026 earnings signal exciting momentum across its three growth pillars. This article breaks down the dri...
AI ambitions collide with power limits. This article explains the gigawatt pivot, why it matters for investors, and w...